Panteleimon E Papakonstantinou
Overview
Explore the profile of Panteleimon E Papakonstantinou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papakonstantinou P, Rivera-Caravaca J, Chiarito M, Ehrlinder H, Iliakis P, Gasecka A, et al.
Trends Cardiovasc Med
. 2025 Jan;
PMID: 39862940
Atrial fibrillation (AF) and atrial myopathy are recognized contributors to cardiovascular morbidity, particularly ischemic stroke. AF poses an elevated risk of thrombogenesis due to irregular heart rhythm leading to blood...
2.
Papakonstantinou P, Lip G
J Cardiovasc Electrophysiol
. 2025 Jan;
36(3):559-563.
PMID: 39807562
No abstract available.
3.
Papakonstantinou P, Aboyans V
Eur J Prev Cardiol
. 2024 Nov;
31(16):1901-1903.
PMID: 39555957
No abstract available.
4.
5.
Konstantinou K, Apostolos A, Tsiachris D, Dimitriadis K, Papakonstantinou P, Pappelis K, et al.
J Hum Hypertens
. 2024 Jul;
38(8):583-594.
PMID: 39026101
Atrial fibrillation (AF) is the most common heart rhythm disorder, especially in people over the age of 50, which affects more than 40 million people worldwide. Many studies have highlighted...
6.
Papakonstantinou P, Kalogera V, Charitos D, Polyzos D, Benia D, Batsouli A, et al.
Blood Rev
. 2024 Feb;
65:101171.
PMID: 38310007
Anticoagulation therapy (AT) is fundamental in atrial fibrillation (AF) treatment but poses challenges in implementation, especially in AF populations with elevated thromboembolic and bleeding risks. Current guidelines emphasize the need...
7.
Kapelios C, Antonopoulos A, Bakogiannis C, Kachrimanidis I, Mantzouranis E, Papakonstantinou P, et al.
Hellenic J Cardiol
. 2023 Nov;
78:90-92.
PMID: 37992894
No abstract available.
8.
Tsiachris D, Papakonstantinou P, Doundoulakis I, Tsioufis P, Botis M, Dimitriadis K, et al.
Medicina (Kaunas)
. 2023 Oct;
59(10).
PMID: 37893599
: The proper use of oral anticoagulants is crucial in the management of non-valvular atrial fibrillation (AF) patients. Left atrial appendage closure (LAAC) may be considered for stroke prevention in...
9.
Coagulation Disorders and Thrombotic Complications in Heart Failure With Preserved Ejection Fraction
Karaban K, Slupik D, Reda A, Gajewska M, Rolek B, Borovac J, et al.
Curr Probl Cardiol
. 2023 Oct;
49(1 Pt C):102127.
PMID: 37802171
Heart failure with preserved ejection fraction (HFpEF) is associated with multiple cardiovascular and noncardiovascular comorbidities and risk factors which increase the risk of thrombotic complications, such as atrial fibrillation, chronic...
10.
Papakonstantinou P, Lentza M, Manousiadis K, Bei I, Panourgia M, Tachmetzidi-Papoutsi D, et al.
Future Cardiol
. 2023 Jul;
19(6):313-322.
PMID: 37449521
Hyperacute synchronous cardiocerebral infarction (CCI) is an extremely rare condition with an incidence of 0.009%. In the acute stage of ischemic stroke, there is a high prevalence of ECG abnormalities....